Status:

COMPLETED

Podocyturia as Predictive Factor for Pre-eclampsia

Lead Sponsor:

Hospices Civils de Lyon

Conditions:

Pre-Eclampsia

Eligibility:

FEMALE

18+ years

Brief Summary

Pre-eclampsia is an hypertensive disorder appearing during pregnancy, inducing serious maternal, fetal and neonatal mortality and morbidity. Podocyn could be identified in the urine, before proteinuri...

Eligibility Criteria

Inclusion

  • women aged 18 years or more
  • single pregnancy
  • first planned prenatal visit before 16 weeks of gestation
  • planned delivery at Hôpital Femme Mère Enfant in Lyon, France
  • patient receiving information and non opposition to participate

Exclusion

  • multiple pregnancy
  • pregnancy stopped
  • antecedent of nephropathy
  • inability to understand information provided
  • prisoner or under administrative supervision
  • fetal malformation, chromosomal anomalies
  • preterm delivery for other reason that any hypertensive disorder of pregnancy or Intrauterine growth restriction

Key Trial Info

Start Date :

May 15 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 7 2021

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT03316430

Start Date

May 15 2019

End Date

December 7 2021

Last Update

January 12 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of obstetrics, Femme Mère Enfant Hospital, Lyon, France

Bron, France, 69677